Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABACAVIR vs EMTRICITABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABACAVIR vs EMTRICITABINE: Safety Overview

Metric ABACAVIR EMTRICITABINE
Total FAERS Reports 4,282 3,718
Deaths Reported 524 499
Death Rate 12.2% 13.4%
Hospitalizations 890 797
Average Patient Age 41.7 yrs 42.2 yrs
% Female Patients 41.3% 41.9%
FDA Approval Date Dec 17, 1998 Jul 2, 2003
Manufacturer Mylan Pharmaceuticals Inc. Gilead Sciences, Inc
Route ORAL ORAL
Marketing Status Discontinued Prescription